Vertex Pharmaceuticals Inc (VRTX) Com Stk
Sell:$429.50Buy:$429.82
$5.00
(1.18%)
NASDAQ:
0.67%
0.67%Market closed |
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$429.50
Buy:$429.82
Change:$5.00
(1.18%)
$5.00
(1.18%)Market closed |
Prices delayed by at least 15 minutes
Sell:$429.50
Buy:$429.82
Change:$5.00
(1.18%)
$5.00
(1.18%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 17 November 2025 | Edward Morrow III AtkinsonCTO | Sell Regular sell transaction (market) | 2,500 | $434.58 | $1,086,450.00 | 16,852 |
| 14 November 2025 | Jeffrey M LeidenExecutive Chairman | Sell Option/Award related | 32,234 | $440.30 | $14,192,630.20 | 45,396 |
| 14 November 2025 | Jeffrey M LeidenExecutive Chairman | Sell Option/Award related | 21,330 | $441.35 | $9,413,995.50 | 24,066 |
| 14 November 2025 | Jeffrey M LeidenExecutive Chairman | Sell Option/Award related | 40 | $442.00 | $17,680.00 | 24,026 |
| 13 November 2025 | Jeffrey M LeidenExecutive Chairman | Sell Option/Award related | 18,528 | $440.22 | $8,156,396.16 | 25,186 |
| 13 November 2025 | Jeffrey M LeidenExecutive Chairman | Sell Option/Award related | 1,160 | $441.05 | $511,618.00 | 24,026 |
| 2 October 2025 | Jonathan Prim BillerChief Legal/Compliance Officer | Sell Option/Award related | 694 | $404.21 | $280,521.74 | 15,653 |
| 1 October 2025 | Jonathan Prim BillerChief Legal/Compliance Officer | Sell Tax related | 1,259 | $400.00 | $503,600.00 | 16,347 |
| 27 August 2025 | Sangeeta N BhatiaIndependent Director | Sell Regular sell transaction (market) | 266 | $386.69 | $102,859.54 | 4,565 |
| 6 August 2025 | Reshma KewalramaniPresident/CEO | Buy Regular purchase transaction | 5,710 | $389.95 | $2,226,614.50 | 115,968 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 July 2025 | Stuart A ArbuckleCOO | Sell Tax related | 37,243 | $450.23 | $16,767,915.89 | 63,368 |
| 14 November 2025 | Jeffrey M LeidenExecutive Chairman | Sell Option/Award related | 32,234 | $440.30 | $14,192,630.20 | 45,396 |
| 14 November 2025 | Jeffrey M LeidenExecutive Chairman | Sell Option/Award related | 21,330 | $441.35 | $9,413,995.50 | 24,066 |
| 13 November 2025 | Jeffrey M LeidenExecutive Chairman | Sell Option/Award related | 18,528 | $440.22 | $8,156,396.16 | 25,186 |
| 26 February 2025 | Reshma KewalramaniPresident/CEO | Sell Tax related | 14,079 | $479.61 | $6,752,429.19 | 105,915 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.